Search Results - "Falda, M"

Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission by Saraceni, F, Bruno, B, Lemoli, R M, Meloni, G, Arcese, W, Falda, M, Ciceri, F, Alessandrino, E P, Specchia, G, Scimè, R, Raimondi, R, Bacigalupo, A, Bosi, A, Onida, F, Rambaldi, A, Bonifazi, F, Olivieri, A

Get full text

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT) by AOUDJHANE, M, LABOPIN, M, SHOUTEN, H, BLAISE, D, FALDA, M, FAUSER, A. A, ESTEVE, J, POLGE, E, SLAVIN, S, NIEDERWIESER, D, NAGLER, A, ROCHA, V, GORIN, N. C, SHIMONI, A, RUUTU, T, KOLB, H.-J, FRASSONI, F, BOIRON, J. M, YIN, J. L, FINKE, J

“…Results of reduced intensity conditioning regimen (RIC) in the HLA identical haematopoietic stem cell transplantation (HSCT) setting have not been compared to…”
Get full text

Treatment of refractory chronic GVHD with rituximab: a GITMO study by ZAJA, F, BACIGALUPO, A, LASZLO, D, ALESSANDRINO, P. E, NARNI, F, SICA, S, OLIVIERI, A, SPEROTTO, A, BOSI, A, BONIFAZI, F, FANIN, R, PATRIARCA, F, STANZANI, M, VAN LINT, M. T, FILI, C, SCIME, R, MILONE, G, FALDA, M, VENER, C

“…The anti-CD20 chimaeric monoclonal antibody Rituximab has recently been shown to induce significant clinical response in a proportion of patients with…”
Get full text

Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus by Allice, Tiziano, Busca, Alessandro, Locatelli, Franco, Falda, Michele, Pittaluga, Fabrizia, Ghisetti, Valeria

“…Objectives Valganciclovir is a well established drug for the management of cytomegalovirus (CMV) infection in haematopoietic stem cell transplantation (HSCT)…”
Get full text

Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis by Busca, A., Cavecchia, I., Locatelli, F., D'Ardia, S., De Rosa, F.G., Marmont, F., Ciccone, G., Baldi, I., Serra, R., Gaido, E., Falda, M.

“…A. Busca, I. Cavecchia, F. Locatelli, S. D' Ardia, F.G. De Rosa, F. Marmont, G. Ciccone, I. Baldi, R. Serra, E. Gaido, M. Falda. Blood stream infections after…”
Get full text

The reversed halo sign as the initial radiographic sign of pulmonary zygomycosis by Busca, A., Limerutti, G., Locatelli, F., Barbui, A., De Rosa, F. G., Falda, M.

“…Zygomycosis is an emerging fungal infection that is associated with high mortality in hematological patients and stem cell transplantation (SCT) recipients…”
Get full text

Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe by Barkholt, L., Bregni, M., Remberger, M., Blaise, D., Peccatori, J., Massenkeil, G., Pedrazzoli, P., Zambelli, A., Bay, J.-O., Francois, S., Martino, R., Bengala, C., Brune, M., Lenhoff, S., Porcellini, A., Falda, M., Siena, S., Demirer, T., Niederwieser, D., Ringdén, O.

“…Background: An allogeneic antitumour effect has been reported for various cancers. We evaluated the experience of allogeneic haematopoietic stem cell…”
Get full text

HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry by Crocchiolo, R, Ciceri, F, Fleischhauer, K, Oneto, R, Bruno, B, Pollichieni, S, Sacchi, N, Sormani, M P, Fanin, R, Bandini, G, Bonifazi, F, Bosi, A, Rambaldi, A, Alessandrino, P E, Falda, M, Bacigalupo, A

“…The importance of HLA donor–recipient matching in unrelated haematopoietic SCT (HSCT) is the subject of debate. In this retrospective study, we analyzed 805…”
Get full text

Comparative analysis of algorithms for whole-genome assembly of pyrosequencing data by FINOTELLO, Francesca, LOVEZZO, Enrico, FONTANA, Paolo, PERUZZO, Denis, ALBIERO, Alessandro, BARZON, Luisa, FALDA, Marco, DI CAMILLO, Barbara, TOPPO, Stefano

“…Next-generation sequencing technologies have fostered an unprecedented proliferation of high-throughput sequencing projects and a concomitant development of…”
Get full text

Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantation by Busca, A., De Fabritiis, P., Ghisetti, V., Allice, T., Mirabile, M., Gentile, G., Locatelli, F., Falda, M.

“…: Antiviral compounds including ganciclovir, foscarnet, and cidofovir are routinely used in the treatment of cytomegalovirus (CMV) infection and disease;…”
Get full text

Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients by Rambaldi, A, Bacigalupo, A, Fanin, R, Ciceri, F, Bonifazi, F, Falda, M, Lambertenghi-Deliliers, G, Benedetti, F, Bruno, B, Corradini, P, Alessandrino, P E, Iacopino, P, Arcese, W, Scimè, R, Raimondi, R, Sica, S, Castagna, L, Lamparelli, T, Oneto, R, Lombardini, L, Pollichieni, S, Algarotti, A, Carobbio, A, Sacchi, N, Bosi, A

“…An unrelated donor (UD) search was submitted to the Italian Bone Marrow Donor Registry between February 2002 and December 2004, for 326 consecutive patients…”
Get full text

Usefulness of Sequential Aspergillus galactomannan Antigen Detection Combined With Early Radiologic Evaluation for Diagnosis of Invasive Pulmonary Aspergillosis in Patients Undergoing Allogeneic Stem Cell Transplantation by Busca, A., Locatelli, F., Barbui, A., Limerutti, G., Serra, R., Libertucci, D., Falda, M.

“…Early diagnosis of invasive pulmonary aspergillosis (IPA) is important as prompt treatment with antifungal drugs may increase patient survival. Our study…”
Get full text

Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone : A multicenter randomized trial from the Italian Group for Bone Marrow Transplantation by VAN LINT, M. T, UDERZO, C, BOSI, A, MINIERO, R, ALESSANDRINO, P, DINI, G, ROTOLI, B, BACIGALUPO, A, LOCASCIULLI, A, MAJOLINO, I, SCIME, R, LOCATELLI, F, GIORGIANI, G, ARCESE, W, IORI, A. P, FALDA, M

“…Ninety-five patients undergoing an allogeneic bone marrow transplant (BMT) and developing acute graft-versus-host disease (aGvHD) were randomized to receive…”
Get full text

AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia : A Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMENA) Pilot Study by AVVISATI, G, LO COCO, F, DIVERIO, D, FALDA, M, FERRARA, F, LAZZARINO, M, RUSSO, D, CONCETTA PETTI, M, MANDELLI, F

“…From March 1993 to October 1993, 20 consecutive, newly diagnosed acute promyelocytic leukemia (APL) patients from 13 Italian institutions entered in a pilot…”
Get full text

Severe thrombotic microangiopathy : an infrequent complication of bone marrow transplantation by IACOPINO, P, PUCCI, G, SICA, S, UDERZO, C, BACIGALUPO, A, ARCESE, W, BOSI, A, FALDA, M, LOCATELLI, F, MARENCO, P, MINIERO, R, MORABITO, F, ROSSETTI, F

Get full text

Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation by Bertinetto, F. E., Dall'Omo, A. M., Mazzola, G. A., Rendine, S., Berrino, M., Bertola, L., Magistroni, P., Caropreso, P., Falda, M., Locatelli, F., Busca, A., Amoroso, A.

“…Summary Graft‐versus‐host disease (GvHD) is the main complication after haematopoietic stem cells transplantation (HSCT) and acute forms (aGvHD) occur in…”
Get full text

Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma by Vitolo, U, Cortellazzo, S, Liberati, A M, Freilone, R, Falda, M, Bertini, M, Botto, B, Cinieri, S, Levis, A, Locatelli, F, Lovisone, E, Marmont, F, Pizzuti, M, Rossi, A, Viero, P, Barbui, T, Grignani, F, Resegotti, L

“…In our previous study with MACOPB, we identified a high-risk group of patients with a poor 3-year survival rate of 29%. These patients were defined as having…”
Get more information

G-CSF administration following peripheral blood progenitor cell (PBPC) autograft in lymphoid malignancies : evidence for clinical benefits and reduction of treatment costs by TARELLA, C, CASTELLINO, C, LOCATELLI, F, CARACCIOLO, D, CORRADINI, P, FALDA, M, NOVARINO, A, TASSI, V, PILERI, A

“…Clinical value and costs of G-CSF administration following autograft with mobilized peripheral blood progenitor cells (PBPC) were evaluated in two sequential…”
Get full text

Infectious complications following nonmyeloablative allogeneic hematopoietic stem cell transplantation by Busca, A., Locatelli, F., Barbui, A., Ghisetti, V., Cirillo, D., Serra, R., Audisio, E., Falda, M.

“…:  Nonmyeloablative hematopoietic stem cell transplantation (NST) has been explored in hematological malignancies and solid tumors in an attempt to minimize…”
Get full text

High rate of remission and low rate of disease recurrence in patients with multiple myeloma allografted with PBSC from their HLA-identical sibling donors by MAJOLINO, I, CORRADINI, P, SANTORO, A, PILERI, A, SCIME, R, FALDA, M, BOSI, A, TARELLA, C, MUSSO, M, OLIVIERI, A, BOCCADORO, M, MARCENO, R

“…A total of 30 multiple myeloma patients (M=23, F=7; age 31-55 years, median 48) were allografted with peripheral blood stem cells (PBSC) from HLA-identical…”
Get full text